NCT05009966 2021-10-25Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid TumorCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Unknown272 enrolled